AstraZeneca buying Alexion in $39B cash and stock deal
AstraZeneca buying Alexion in $39B cash and stock deal
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
AstraZeneca stock price falls sharply on a $39 billion bill to buy Alexion
Invezz
Investors don’t seem impressed with AstraZeneca’s (LON: AZN) latest deal, which is also the biggest deal in the company’s..
-
Alexion, Pluralsight rise; SolarWinds, Virgin Galactic fall
SeattlePI.com
-
The Alexion Takeover Is a Major Expansion for AstraZeneca. Why the Stock Is Down 7%
Upworthy
-
AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal
Upworthy
-
AstraZeneca swoops with US$39bn bid for rare disease specialist Alexion
Proactive Investors
Advertisement
More coverage
UK's Astrazeneca buying US Biotech firm Alexion for 39 Billion dollars to expand in immunology
Mid-Day
British pharmaceuticals group AstraZeneca, which is finalising a vaccine against Covid-19, said Saturday it was buying US biotech..